Furthermore, high IL-6 levels in amniotic fluid (AF) have been associated with subsequent pregnancy loss [97] as well as to PTD and fetal growth restriction [98,99] thus suggesting that the primary efforts to prevent and counteract all these adverse outcomes should be addressed to counteract the underneath inflammatory disorders. This evidence concerns the gene IL6 and Bjornstad syndrome.